Composition Methylergometrine (0.125mg)
Rx Prescription Required
Pack vial of 1 ml Injection
Storage Store in a refrigerator (2 – 8°C). Do not freeze.
Chemical Class Ergolines
Action Class Uterotonic and abortificient
Habbit Forming No
Manufacturer Mercury Laboratories Ltd
Manufacturer address 12-B, Girichhaya, Loyalka Estate, Chowpatty Band Stand, Mumbai – 400 006. INDIA
Methylergometrine (0.125mg)
PRIMARY PRODUCT
VIEW AVAILABLE SUBSTITUTES
Ergagin 0.125mg Injection
Ergagin 0.125mg Injection is a medicine used to control bleeding from the uterus, that may occur after childbirth or an abortion. It works on the smooth muscle of the uterus and increases tone, rate, and amplitude of contractions thus reduces blood loss.
Basic Info
Description
Ergagin 0.125mg Injection is not for a self-administered, it is given as an injection into the veins or muscles by the doctor at hospital setting. It should be taken as your doctor’s advice. The dose and how often you take it depends on what you are taking it for. Your doctor will decide how much you need to improve your symptoms.
The most common side effects of this medicine include headache, increase in blood pressure and seizure. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them. Generally, alcohol should be avoided while taking this medicine.
Before taking this medicine, let your doctor know if you have ever had heart disease or you have high blood pressure. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works.
Uses
Post-delivery bleeding
How To Use
Your doctor or nurse will give you this medicine. Kindly do not self administer.
MOA
Ergagin 0.125mg Injection is an ergot alkaloid. It works by causing sustained contractions of the smooth muscles of the uterus. This results in compression of the blood vessels which controls bleeding after delivery.
What If
Information not available at the moment. Please check back later.
Drug Tips
Ergagin 0.125mg Injection is used for the prevention and control of post-delivery bleeding.
It may also be used for the active management of the third stage of labor, to facilitate the delivery of the placenta.
It is given intravenously (into a vein) or intramuscularly (into the muscle) by a doctor or healthcare provider in a hospital or clinic.
Its dose may be repeated as required at intervals of 2 to 4 hours.
It should be avoided in patients, with high blood pressure, and heart disease.
Faqs
Information not available at the moment. Please check back later.
Benifits
In Post-delivery bleeding
Ergagin 0.125mg Injection helps to control excessive bleeding after giving birth. This helps to prevent severe loss of blood that can lead to dropping of blood pressure, shock and even death if not controlled in time. It helps proper contraction of the uterus and therefore prevents hemorrhage and further complications.
Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Seizure
Headache
High blood pressure
Safety Profile
Alcohol:CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Ergagin 0.125mg Injection. Please consult your doctor.
Pregnancy:UNSAFE
Ergagin 0.125mg Injection is highly unsafe to use during pregnancy. Seek your doctor’s advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Breast feeding:CAUTION
Ergagin 0.125mg Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Driving:CONSULT YOUR DOCTOR
It is not known whether Ergagin 0.125mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney:CONSULT YOUR DOCTOR
There is limited information available on the use of Ergagin 0.125mg Injection in patients with kidney disease. Please consult your doctor.
Liver:CONSULT YOUR DOCTOR
There is limited information available on the use of Ergagin 0.125mg Injection in patients with liver disease. Please consult your doctor.
